NCT07609693 The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study
| NCT ID | NCT07609693 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tokat Gaziosmanpasa University |
| Condition | Lactation Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2026-05-12 |
| Primary Completion | 2026-05-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2026-05-12 with a primary completion date of 2026-05-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effects of oxytocin massage on breastfeeding self-efficacy and the milk ejection reflex among mothers experiencing insufficient milk supply in the early postpartum period. Insufficient milk supply is a common issue often linked to maternal stress, which can inhibit oxytocin release and negatively impact the milk ejection reflex and the mother's confidence in breastfeeding. By applying oxytocin massage to the thoracic paravertebral region, this study seeks to stimulate oxytocin release non-pharmacologically. The primary objective is to determine whether this intervention improves physiological milk flow and enhances maternal breastfeeding self-efficacy compared to routine postpartum care.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older * Being in the early postpartum period (within the first 24-48 hours after birth) * Having had a single, live birth via vaginal delivery or cesarean section * Having a term (≥37 weeks) and healthy baby * Being in the same room as the baby (rooming-in practice) * Having started breastfeeding * Reporting insufficient milk production or expressing difficulty with the milk let-down reflex * Not having a cognitive, neurological, or serious psychiatric problem that would impede communication * Voluntary participation in the study and providing written informed consent Exclusion Criteria: * Having given birth preterm (\<37 weeks) * Having given birth as a result of a multiple pregnancy * Having been admitted to the neonatal intensive care unit (NICU) * The baby having a congenital anomaly that prevents breastfeeding (e.g., cleft lip and palate) * The mother having medical conditions that contraindicate breastfeeding (HIV infection, active tuberculosis, etc.) * The mother developing serious postpartum complications (postpartum hemorrhage, eclampsia, serious infection, etc.) * The presence of anatomical or pathological conditions related to the breast that may prevent breastfeeding (advanced mastitis, breast abscess, etc.) * The presence of skin lesions, surgical incisions, or infections in the back that would prevent the application of oxytocin massage * Failure to complete the intervention or wishing to withdraw from the study will be excluded.
Contact & Investigator
Elif TAĞTEKİN, student
PRINCIPAL INVESTIGATOR
Kahramanmaras Sutcu Imam University Department of Midwifery
Frequently Asked Questions
Who can join the NCT07609693 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Lactation Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07609693 currently recruiting?
Yes, NCT07609693 is actively recruiting participants. Contact the research team at emineaksutakcay@ksu.edu.tr/ for enrollment information.
Where is the NCT07609693 trial being conducted?
This trial is being conducted at Kahramanmaraş, Turkey (Türkiye).
Who is sponsoring the NCT07609693 clinical trial?
NCT07609693 is sponsored by Tokat Gaziosmanpasa University. The principal investigator is Elif TAĞTEKİN, student at Kahramanmaras Sutcu Imam University Department of Midwifery. The trial plans to enroll 128 participants.